Genetic Technologies
GENE
#10471
Rank
โ‚น0.33 B
Marketcap
โ‚น70.11
Share price
0.00%
Change (1 day)
-66.84%
Change (1 year)

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

In 2023 the company made an earnings per share (EPS) of -โ‚น3.05 a decrease over its 2022 EPS that were of -โ‚น2.02.

EPS history for Genetic Technologies from 2001 to 2018

Annual EPS

Year EPS Change
2023-โ‚น3.0550.65%
2022-โ‚น2.02-99.04%
2021-โ‚น210.16-46.67%
2020-โ‚น394.06-99.38%
2019-โ‚น63,04910809.09%
2018-โ‚น577.95-41.07%
2017-โ‚น980.76-18.37%
2016-โ‚น1,201-40.24%
2015-โ‚น2,011-53.41%
2014-โ‚น4,315-10.66%
2013-โ‚น4,83071.3%
2012-โ‚น2,820-622.73%
2011โ‚น539.42-108.8%
2010-โ‚น6,130-3.92%
2009-โ‚น6,38073.47%
2008-โ‚น3,67824.96%
2007-โ‚น2,943-10.93%
2006-โ‚น3,304-48.62%
2005-โ‚น6,431-8.31%
2004-โ‚น7,014
2003N/A-100%
2002-โ‚น4,355-9.36%
2001-โ‚น4,805

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,589N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น791.78N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚น447.21N/A๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น939.32N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น27.49N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
-โ‚น253.90N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚น396.81N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,030N/A๐Ÿ‡บ๐Ÿ‡ธ USA